ARKG ETF — Holdings & Market Internals
A visuals-first look inside ARK Genomic Revolution ETF (ARKG): a weight-sized holdings treemap, sector concentration, and the breadth oscillators that reveal whether the fund's move is broad or narrow — built on the live 32-name holdings snapshot.
Historical breadth is computed against the current ARKG membership, so older values carry a degree of survivorship bias (constituents removed from the fund are excluded from past readings).
Holdings Treemap
Tile size = ETF weight, grouped by sector. Color by:
Sector Weights
Share of the fund by GICS-style sector.
Market Breadth Snapshot
How many constituents are participating in the trend. See the full internals →
Trend Alignment
Cap-weighted share of the fund by where price sits across its 20/50/200-day SMAs — 81% is in full alignment.
Valuation & Fundamentals
Sector multiples and dispersion across holdings (cap-weighted harmonic mean). Full valuation →
Valuation by Sector & Distribution
Fund P/E: 37.3 — cap-weighted harmonic mean. Green = cheaper than the fund.
By sector (cap-weighted)
Distribution across holdings
One-Month Leaders
Strongest constituents over the trailing month.
| PACB | Pacific Biosciences of California, Inc. | 1.24% | +115.79% | 89 |
| QSI | Quantum-Si Incorporated Class A Common Stock | 0.45% | +66.91% | 67 |
| TXG | 10x Genomics, Inc. Class A Common Stock | 10.04% | +56.76% | 80 |
| SDGR | Schrodinger, Inc. Common Stock | 3.10% | +55.02% | 75 |
| TWST | Twist Bioscience Corporation Common Stock | 10.23% | +54.31% | 76 |
| CDNA | CareDx, Inc. | 4.51% | +40.40% | 84 |
One-Month Laggards
Weakest constituents — candidates for the opportunity scan.
| BEAM | Beam Therapeutics Inc. Common Stock | 2.98% | -12.95% | 50 |
| PRME | Prime Medicine, Inc. Common Stock | 1.05% | -13.24% | 51 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 1.66% | -13.70% | 42 |
| GENB | Generate Biomedicines, Inc. Common Stock | 0.98% | -15.18% | 38 |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | 1.74% | -28.00% | 30 |
| SCTX | Scribe Therapeutics Inc. Common Stock | 0.58% | -47.71% | 31 |
Holdings Explorer
Top 30 by weight — sort any column. View all 32 holdings →
| TWST | Twist Bioscience Corporation Common Stock | Health Care | 10.23% | $206.50 | +8.77% | +54.31% | +105.45% | 76 | 100 | $12.5B |
| TXG | 10x Genomics, Inc. Class A Common Stock | Industrials | 10.04% | $98.24 | +4.67% | +56.76% | +145.45% | 80 | 100 | $12.2B |
| TEM | Tempus AI, Inc. Class A Common Stock | Technology | 8.51% | $83.35 | +9.11% | +32.62% | +37.99% | 64 | 49 | $13.9B |
| CRSP | CRISPR Therapeutics AG | Health Care | 5.36% | $57.35 | +3.21% | -0.28% | -8.18% | 56 | 41 | $5.4B |
| ABSI | Absci Corporation Common Stock | Health Care | 5.15% | $11.55 | +4.16% | +29.41% | -2.70% | 67 | 99 | $1.9B |
| PSNL | Personalis, Inc. Common Stock | Health Care | 4.94% | $16.43 | +0.92% | -3.24% | +17.31% | 55 | 98 | $1.7B |
| GH | Guardant Health, Inc. Common Stock | Health Care | 4.61% | $186.00 | +5.39% | +14.10% | +11.42% | 67 | 99 | $23.9B |
| NTRA | Natera, Inc. Common Stock | Health Care | 4.57% | $427.40 | +3.72% | +30.70% | +49.60% | 82 | 99 | $59.1B |
| CDNA | CareDx, Inc. | Health Care | 4.51% | $69.85 | +3.96% | +40.40% | +137.91% | 84 | 100 | $3.5B |
| ILMN | Illumina Inc | Health Care | 4.45% | $293.75 | +7.61% | +37.73% | +51.45% | 77 | 99 | $41.2B |
| LLY | Eli Lilly & Co. | Health Care | 3.40% | $1145.91 | +0.28% | -2.30% | -7.28% | 43 | 91 | $1.02T |
| SDGR | Schrodinger, Inc. Common Stock | Health Care | 3.10% | $32.97 | +7.52% | +55.02% | +91.76% | 75 | 93 | $2.3B |
| BEAM | Beam Therapeutics Inc. Common Stock | Health Care | 2.98% | $25.50 | +4.90% | -12.95% | -29.89% | 50 | 62 | $2.5B |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | Health Care | 2.58% | $4.76 | +16.26% | +39.16% | +21.01% | 72 | 46 | $2.2B |
| CMPS | COMPASS Pathways Plc American Depository Shares | Health Care | 2.48% | $11.59 | -2.56% | -10.97% | -1.28% | 33 | 97 | $1.6B |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | Health Care | 2.26% | $29.76 | +5.33% | +18.51% | +39.64% | 65 | 97 | $4.5B |
| VCYT | Veracyte, Inc. | Health Care | 2.11% | $47.77 | +4.04% | +5.09% | -18.02% | 59 | 88 | $3.7B |
| BFLY | Butterfly Network, Inc. | Health Care | 1.89% | $9.44 | +5.59% | +21.98% | +15.23% | 59 | 100 | $2.4B |
| NRIX | Nurix Therapeutics, Inc. Common stock | Health Care | 1.83% | $22.89 | -0.35% | -11.39% | -4.98% | 34 | 98 | $2.4B |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | Health Care | 1.74% | $43.63 | -0.11% | -28.00% | -48.47% | 30 | 32 | $7.2B |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | Health Care | 1.69% | $14.62 | +12.51% | -12.58% | +99.73% | 55 | 34 | $370M |
| WGS | GeneDx Holdings Corp. Class A Common Stock | Health Care | 1.66% | $75.08 | +4.15% | -13.70% | +10.38% | 42 | 33 | $2.2B |
| NTLA | Intellia Therapeutics, Inc | Health Care | 1.57% | $12.74 | +4.16% | -0.86% | -28.57% | 57 | 32 | $1.7B |
| ALMR | Alamar Biosciences, Inc. Common Stock | Industrials | 1.45% | $37.40 | +11.26% | +23.68% | +47.68% | 68 | 0 | $2.2B |
| PACB | Pacific Biosciences of California, Inc. | Industrials | 1.24% | $2.88 | +13.39% | +115.79% | +72.89% | 89 | 97 | $790M |
| MASS | 908 Devices Inc. Common Stock | Industrials | 1.11% | $12.88 | +0.83% | +23.20% | +54.03% | 75 | 91 | $525M |
| PRME | Prime Medicine, Inc. Common Stock | Health Care | 1.05% | $3.27 | +8.05% | -13.24% | -20.54% | 51 | 29 | $541M |
| GENB | Generate Biomedicines, Inc. Common Stock | Health Care | 0.98% | $13.89 | +1.68% | -15.18% | -17.84% | 38 | 0 | $1.8B |
| CERS | Cerus Corp | Health Care | 0.81% | $2.35 | +2.41% | -11.36% | -29.31% | 38 | 93 | $459M |
| SCTX | Scribe Therapeutics Inc. Common Stock | Health Care | 0.58% | $16.01 | -3.34% | -47.71% | -- | 31 | 0 | $403M |